Flo vs Ovia 2026: Privacy, Features & Price Compared
Our verdict
Flo paid $8M in a class action for sharing data with Google and Meta. Ovia is owned by Labcorp and shares health data with employers through enterprise partnerships. Both prioritize their business models over your privacy. PinkyBloom's zero-knowledge architecture makes data sharing architecturally impossible — for free.
Flo vs Ovia vs PinkyBloom
| Feature | Flo | Ovia | PinkyBloom |
|---|---|---|---|
| Price | ~$49.99/yr premium | Free (employer-subsidized) | Free forever |
| Users | 440M+ | Millions | Growing |
| Data storage | Cloud (Flo servers) | Cloud (Labcorp servers) | On-device only |
| Privacy track record | $56M class action settlement | Mozilla *Privacy Not Included | Zero-knowledge architecture |
| Corporate owner | Flo Health Inc. | Labcorp ($15B+ lab corp) | Independent |
| Employer data sharing | Yes (Ovia+ enterprise) | ||
| AI assistant | Cloud-based chatbot | On-device AI | |
| Voice logging | |||
| Mood forecasts | |||
| Pregnancy tracking | Yes (Flo mode) | Yes (separate Ovia app) | Yes (built-in) |
| Doctor visit reports | |||
| Ads | Ads in free tier | No ads (employer-funded) | No ads ever |
Overview
Flo and Ovia are both popular women's health apps, but they serve different markets. Flo is a consumer-first platform with 440 million users, offering period tracking, pregnancy content, community forums, and a health chatbot. Ovia is increasingly an enterprise product — owned by Labcorp, it sells Ovia+ to employers and health plans who want analytics on their employees' reproductive health.
Flo's value proposition is breadth: 70+ symptoms, thousands of articles from 120+ medical experts, and a large community. Ovia's value proposition is pregnancy and fertility support, with three separate apps (Fertility, Pregnancy, Parenting) and employer-sponsored health coaching.
The critical question isn't which app has better features — it's who benefits from your data. With Flo, advertisers benefited (until they got caught). With Ovia, your employer and health plan benefit through Labcorp's enterprise analytics. Both apps monetize user health data as a core part of their business model.
Privacy comparison
This comparison involves two of the most concerning privacy models in the period tracking industry.
Flo's violations are documented in federal court. The FTC found Flo shared menstrual data with Google, Facebook, and analytics firms. A $56M class action settlement followed. A California jury found Meta guilty of eavesdropping on Flo users' data. Flo's track record is the industry's worst.
Ovia's model is different but equally concerning. As a subsidiary of Labcorp — a $15 billion clinical laboratory company — Ovia's business fundamentally depends on monetizing user health data through enterprise partnerships. Ovia+ gives employers and health plans access to employee reproductive health analytics. Mozilla gave Ovia a "Privacy Not Included" rating. Snopes confirmed mandatory location data collection.
The distinction matters: Flo got caught sharing data without permission. Ovia's data sharing is the business model — it's designed to flow to corporate partners. For users, the result is the same: your most intimate health information exists on servers controlled by companies with financial incentives to use it.
PinkyBloom has no corporate parent, no enterprise customers, and no servers. Your data lives on your iPhone, protected by zero-knowledge architecture, Apple's Secure Enclave, and Face ID. There's no data to share because there's no data anywhere except your device.
Features and intelligence
Flo covers more ground: 70+ symptoms, AI chatbot, community forums, pregnancy mode, and content from medical experts. It's designed as an all-in-one health platform. The AI chatbot processes data on cloud servers, which is the same architectural pattern that enabled its privacy violations.
Ovia focuses on the fertility-to-parenting journey with three dedicated apps and daily fertility scores. The employer-sponsored Ovia+ tier adds health coaching. However, the intelligence layer is content-driven — articles, tips, and milestone tracking — rather than AI-powered. The three-app structure fragments the user experience.
PinkyBloom consolidates all life stages into a single app with genuine AI intelligence. On-device AI provides personalized insights without cloud processing. Voice logging captures symptoms hands-free. AI mood forecasts predict emotional patterns. The doctor visit report generator creates professional health summaries. Encrypted partner sharing through PinkyBond replaces cloud-based sharing features. One app, all life stages, zero servers.
Pricing comparison
Flo's premium costs ~$49.99/year with a free ad-supported tier. Ovia's consumer app is free, but the "free" is subsidized by employers paying Labcorp for access to employee health analytics. When a $15B lab corporation gives you a free app, you are the product.
The pricing comparison is actually about hidden costs. Flo's hidden cost was discovered in court: your data shared with advertisers. Ovia's hidden cost is by design: your reproductive health data flowing to your employer's analytics dashboard.
PinkyBloom is free with no hidden costs. No subscription, no ads, no employer partnerships, no corporate parent company. Every feature included. The total cost — financial and otherwise — is zero.
There's a better option
Flo shares your data with advertisers. Ovia shares it with your employer through Labcorp. PinkyBloom can't share your data because it never leaves your iPhone. Zero-knowledge architecture, on-device AI, every feature free. Your reproductive health data belongs to you — not advertisers, not your employer, not a $15B lab corporation.
በአፕ ስቶር ላይ አውርድ